Environmental Measures In The Federal Budget 2008

Starting October 5, 2026, Québec will introduce a new statutory warranty of good working order for consumer goods such as appliances and electronics, with minimum warranty periods ranging from 3 to 6 years. The legislation imposes disclosure obligations on manufacturers and merchants while prohibiting any attempts to exclude or limit this warranty. Businesses operating in Québec must adapt their practices to comply with these consumer protection requirements or face potential compliance issues.

À compter du 5 octobre 2026, une nouvelle garantie légale de bon fonctionnement s'appliquera aux électroménagers et appareils électroniques neufs vendus ou loués à long terme au Québec. Cette garantie, découlant de la Loi 29, impose de nouvelles obligations aux commerçants et fabricants, de l'affichage des prix au traitement des réclamations. Découvrez les biens visés, les durées applicables et les étapes concrètes pour assurer

Health Canada's recent enforcement action against unauthorized injectable peptides signals a regulatory shift that wellness companies cannot afford to ignore. While peptides dominate influencer marketing and online wellness spaces, their legal status in Canada depends on factors far more complex than social media trends suggest. Understanding how route of administration, therapeutic claims, and market authorization intersect is now critical for compliance.

Starting October 5, 2026, Quebec will implement a new legal warranty of good working order for household appliances and electronic devices, requiring merchants and manufacturers to adapt their practices from price display to claims handling. What obligations will businesses face under Bill 29's amendments to the Consumer Protection Act, and how can they prepare for compliance before the deadline?

Canada maintains a sophisticated yet largely voluntary system for regulating food-contact materials, placing primary responsibility on industry to ensure packaging safety. While Health Canada offers Letters of No Objection (LONOs) as written assurances, this regulatory framework may soon shift toward a mandatory positive list approach, fundamentally changing how food packaging materials are assessed and approved in the Canadian market.

Health Canada has introduced mandatory performance standards for consumer products containing button/coin batteries, requiring immediate compliance from manufacturers, importers, advertisers, and sellers. Companies must now certify that their products, packaging, and labelling meet specified safety criteria or equivalent standards to mitigate ingestion hazards. This regulatory update offers a more flexible, outcomes-based approach compared to the prescriptive requirements of Reese's Law in the United States

Quebec's new Bill 24 prohibits businesses from using a person's identity or image in consumer advertising without consent, creating significant compliance obligations for companies using AI-generated content, synthetic voices, and digitally altered spokespersons. The legislation introduces broad enforcement powers and extends liability beyond content creators to platforms that distribute or facilitate unauthorized representations.

Health Canada has launched a public consultation on a proposed regulatory overhaul that would fundamentally transform how food packaging materials are evaluated and approved for use in Canada. The agency is considering implementing a mandatory notification system and potentially creating a binding positive list of approved substances, marking a significant departure from the current voluntary Letter of No Objection framework.

In August, the Federal Trade Commission (the "FTC"), the federal U.S. agency equivalent to Canada's Competition Bureau, issued a rule (the "Rule") to combat fake reviews and testimonials. The Rule

British Columbia's consumer protection amendments take effect August 1, 2026, introducing significant changes to subscription contracts, direct sales restrictions, and disclosure requirements. Businesses must review their contracts and practices to ensure compliance with new cancellation rights, prohibited terms, and enhanced consumer protections.

Effective September 8, 2026, Canada implemented retaliatory tariffs on certain U.S. goods in response to the initial 50% tariffs imposed by the US under Section 338 of the Tariff Act of 1930. To operationalize these measures, the Canada Border Services Agency (CBSA) issued Customs Notice 26-23, establishing binding administrative rules on how the surtax will be applied, calculated, and collected.

This Bulletin summarizes key regulatory developments impacting the payments sector in 2025 and looks ahead to 2026.

With Labour Day now behind us, Parliament Hill is gearing up for its September 21 return. Canada’s counter-tariffs on nearly $28 billion in American goods are now in force, and the United States has already escalated in response: President Trump has signed measures to ban certain Canadian alcohol, dairy-related products, molasses, non-alcoholic beer, motorcycles and mopeds from entering the U.S. market as of September 29, while modifying the list of Canadian goods subject to 50% tariffs effective September 15 and directing action to remove Canadian-origin products from U.S. government procurement schedules.

Under Order in Council 1358-2026, the Québec government authorizes, from September 7, 2026 to January 31, 2027, the Centre d'acquisitions gouvernementales (the “CAG”) to depart from the general principle that public calls for tenders must be open and without discrimination to foreign suppliers from jurisdictions bound by an intergovernmental agreement with Québec.

Canada has announced the imposition of new tariffs on US goods beginning on September 8, 2026. Canada’s retaliatory tariffs were introduced in response to US tariffs on Canadian goods that entered into force on August 22, 2026.

A regulatory shift now under consideration in Ontario could reshape how the province’s medical aesthetic clinics operate. The proposal, which would change how nurses are authorized to administer medical aesthetic services, invites a broader look at how Ontario currently regulates cosmetic injections and how the proposed changes would align the province more closely with the regulatory frameworks already in place elsewhere in Canada. While these procedures are often marketed as routine “spa” services, they remain medical acts that involve prescription products and carry clinical risks.

The Office of the Superintendent of Financial Institutions (OSFI) published its third quarterly release of the year on September 10, 2026, noting that the targeted adjustments made to its guidance were made with a view to supporting a resilient and competitive Canadian financial system.

On July 29, 2026, Health Canada announced that it had obtained a permanent injunction against a Québec-based company in connection with the sale of unauthorized injectable peptides in Canada. The announcement reflects Health Canada’s continued focus on peptide products and serves as a reminder that injectable peptides intended for human use are regulated as prescription drugs and are subject to Canada's drug regulatory framework.

The new framework effectively positions public drug and supplemental benefits plans as payers of last resort. Where a member is entitled to alternative coverage, that coverage must be accessed first, and the public plan will only pay in limited circumstances and only up to the unpaid portion of the claim.

Unmanned Aerial Systems (UAS), commonly referred to as drones, are increasingly used in Canada for commercial purposes such as infrastructure inspection, real estate photography, agriculture, filmmaking, mapping and resource exploration. Their advantages are clear: they are flexible, relatively inexpensive and capable of collecting information from angles and locations that would otherwise be difficult to access.